Cochrane Abstracts
Aminoadamantanes for chronic hepatitis C
There's more to see -- the rest of this topic is available only to subscribers.
Citation
"Aminoadamantanes for Chronic Hepatitis C." Cochrane Abstracts, John Wiley & Sons, Inc, 2025. Evidence Central, evidence.unboundmedicine.com/evidence/view/Cochrane/438780/all/Aminoadamantanes_for_chronic_hepatitis_C.
Aminoadamantanes for chronic hepatitis C. Cochrane Abstracts. John Wiley & Sons, Inc; 2025. https://evidence.unboundmedicine.com/evidence/view/Cochrane/438780/all/Aminoadamantanes_for_chronic_hepatitis_C. Accessed September 24, 2025.
Aminoadamantanes for chronic hepatitis C. (2025). In Cochrane Abstracts. John Wiley & Sons, Inc. https://evidence.unboundmedicine.com/evidence/view/Cochrane/438780/all/Aminoadamantanes_for_chronic_hepatitis_C
Aminoadamantanes for Chronic Hepatitis C [Internet]. In: Cochrane Abstracts. John Wiley & Sons, Inc; 2025. [cited 2025 September 24]. Available from: https://evidence.unboundmedicine.com/evidence/view/Cochrane/438780/all/Aminoadamantanes_for_chronic_hepatitis_C.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Aminoadamantanes for chronic hepatitis C
ID - 438780
BT - Cochrane Abstracts
UR - https://evidence.unboundmedicine.com/evidence/view/Cochrane/438780/all/Aminoadamantanes_for_chronic_hepatitis_C
PB - John Wiley & Sons, Inc
DB - Evidence Central
DP - Unbound Medicine
ER -
